Related Experiment Video
Updated: Jun 7, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic
Hongkun Hu1, Jinxin Tang1, Hua Wang1
1Department of Orthopaedics, Hunan Key Laboratory of Tumor Models and Individualized Medicine, Hunan Engineering Research Center of Artificial Intelligence-Based Medical Equipment, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
Abstract:
RNA splicing is a fundamental step of gene expression. While constitutive splicing removes introns and joins exons unbiasedly, alternative splicing (AS) selectively determines the assembly of exons and introns to generate RNA variants corresponding to the same transcript. The biogenesis of circular RNAs (circRNAs) is inextricably associated with AS. Back-splicing, the biogenic process of circRNA, is a special form of AS. In cancer, both AS and circRNA deviate from the original track. In the present review, we delve into the intricate interplay between AS and circRNAs in the context of cancer. The relationship between AS and circRNAs is intricate, where AS modulates the biogenesis of circRNAs and circRNAs in return regulate AS events. Beyond that, epigenetic and posttranscriptional modifications concurrently regulate AS and circRNAs. On the basis of this modality, we summarize current knowledge on how splicing factors and other RNA binding proteins regulate circRNA biogenesis, and how circRNAs interact with splicing factors to influence AS events. Specifically, the feedback loop regulation between circRNAs and AS events contributes greatly to oncogenesis and cancer progression. In summary, resolving the crosstalk between AS and circRNA will not only provide better insight into cancer biology but also provoke novel strategies to combat cancer.
Insights
Alternative splicing (AS) and circular RNAs (circRNAs) are dysregulated in cancer. This review explores their complex interplay, revealing how they mutually regulate each other and contribute to cancer progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Expression Regulation
Background:
- Alternative splicing (AS) generates diverse RNA variants from a single gene.
- Circular RNAs (circRNAs) are formed through a specific type of AS called back-splicing.
- Both AS and circRNA biogenesis are altered in cancer, impacting cellular function.
Purpose of the Study:
- To review the intricate relationship between alternative splicing and circular RNAs in cancer.
- To summarize how splicing factors and RNA-binding proteins regulate circRNA biogenesis.
- To elucidate how circRNAs influence alternative splicing events and contribute to oncogenesis.
Main Methods:
- Literature review of studies investigating the crosstalk between AS and circRNAs in cancer.
- Analysis of regulatory mechanisms involving splicing factors, RNA-binding proteins, and epigenetic modifications.
- Synthesis of current knowledge on the feedback loops between circRNAs and AS in cancer progression.
Main Results:
- AS modulates circRNA biogenesis, and circRNAs, in turn, regulate AS events.
- Epigenetic and posttranscriptional modifications concurrently influence both AS and circRNAs.
- The feedback loop between circRNAs and AS significantly contributes to oncogenesis and cancer progression.
Conclusions:
- Understanding the crosstalk between AS and circRNAs provides crucial insights into cancer biology.
- Targeting the AS-circRNA axis offers potential novel strategies for cancer therapy.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
lncRNA - Long Non-coding RNAs
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

